SCHEMBL29417844

SCHEMBL29417844

COc1ccc2c(n1)N(C1CCN(C(=O)OC(C)(C)C)CC1)C(=O)CN2

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.47
CTSE P14091 1/20 0.47
BACE1 P56817 1/20 0.47
OPRL1 P41146 1/20 0.43
ALDH1A1 P00352 2/20 0.43
GPR119 Q8TDV5 8/20 0.42
HTT P42858 1/20 0.41
HCAR1 Q9BXC0 1/20 0.40
PIK3CA P42336 1/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20996019 1.00 CTSD (0.47) CTSDCTSEBACE1OPRL1ALDH1A1
SCHEMBL29417834 0.77 GPR119 (0.43) CTSDCTSEBACE1GPR119HCAR1
SCHEMBL29417833 0.72 DDB1 (0.42) CTSDCTSEBACE1GPR119HCAR1
SCHEMBL19706828 0.72 PIK3CA (0.47) CTSDCTSEBACE1ALDH1A1GPR119
SCHEMBL1198502 0.72 CCR5 (0.46) CTSDCTSEBACE1ALDH1A1GPR119
Methane SCHEMBL19706835 0.71 PIK3CA (0.46) CTSDCTSEBACE1ALDH1A1GPR119
SCHEMBL1711818 0.70 PIK3CA (0.49) CTSDCTSEBACE1ALDH1A1GPR119
SCHEMBL27101023 0.69 PIK3CA (0.48) CTSDCTSEBACE1ALDH1A1GPR119
SCHEMBL16992253 0.69 MAPT (0.50) CTSDCTSEBACE1ALDH1A1GPR119
SCHEMBL31639499 0.69 GPR119 (0.50) ALDH1A1GPR119HTTPIK3CAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022051567-A1 SUBSTITUTED PYRIDO[2,3-B]PYRAZINONES AND REUATED COMPOUNDS AND THEIR USE IN TREATING MEDICAU CONDITIONS Ikena Oncology, Inc. (US) 2022-03-10 WO disclosed